Skip to content

Second Opinion

Make us preferred on Google

Comments, opinions, and spicy takes from across the industry.

How India is leading a cancer revolution

How India is leading a cancer revolution

The story of how an Indian biotech startup slashed the cost of CAR-T from $475,000 to just $30,000 and started a revolution in global CAR-T therapy access.

Finding balance in the noise

Finding balance in the noise

"Almost a third of over-65s will fall each year," but could nGVS represent a discreet tool against imbalance?

More than just a headache

More than just a headache

“Pain is treated like a badge of honor" in medicine, but the cost is a workforce breaking under invisible pressure.